Compounds of the formula I in which R, R
1
and R
2
have the meanings indicated in Claim
1
, are PI3K inhibitors and can be employed, inter alia, for the treatment of autoimmune diseases, inflammation, cardiovascular diseases, neurodegenerative diseases and tumours.
[EN] PIPERAZINE BIS-AMIDE DERIVATIVES AND THEIR USE AS ANTAGONISTS OF THE OREXIN RECEPTOR<br/>[FR] DERIVES BIS-AMIDE DE PIPERAZINE ET LEUR UTILISATION EN TANT QU'ANTAGONISTES DU RECEPTEUR D'OREXINE
申请人:SMITHKLINE BEECHAM PLC
公开号:WO2003041711A1
公开(公告)日:2003-05-22
This invention relates to piperazine bis-amide derivatives and their use as pharmaceuticals.
Sargent, Melvyn V., Journal of the Chemical Society. Perkin transactions I, 1987, p. 231 - 236